These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 28633138)
21. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18. Baxevanis CN; Gritzapis AD; Papamichail M J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319 [TBL] [Abstract][Full Text] [Related]
22. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388 [TBL] [Abstract][Full Text] [Related]
23. TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. Papadakis KA; Prehn JL; Landers C; Han Q; Luo X; Cha SC; Wei P; Targan SR J Immunol; 2004 Jun; 172(11):7002-7. PubMed ID: 15153521 [TBL] [Abstract][Full Text] [Related]
24. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999 [TBL] [Abstract][Full Text] [Related]
25. Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12. Singh SM; Yanagawa H; Hanibuchi M; Miki T; Okamura H; Sone S Int J Immunopharmacol; 2000 Jan; 22(1):35-43. PubMed ID: 10684987 [TBL] [Abstract][Full Text] [Related]
26. IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Cai G; Kastelein RA; Hunter CA Eur J Immunol; 1999 Sep; 29(9):2658-65. PubMed ID: 10508240 [TBL] [Abstract][Full Text] [Related]
27. Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes. Ogata K; Tamura H; Yokose N; An E; Dan K; Hamaguchi H; Sakamaki H; Onozawa Y; Clark SC; Nomura T Br J Haematol; 1995 May; 90(1):15-21. PubMed ID: 7786778 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells. Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-21 increases direct cytotoxicity and IFN-γ production of ex vivo expanded NK cells towards breast cancer cells. Park YK; Shin DJ; Cho D; Kim SK; Lee JJ; Shin MG; Ryang DW; Lee JS; Park MH; Yoon JH; Jegal YJ Anticancer Res; 2012 Mar; 32(3):839-46. PubMed ID: 22399602 [TBL] [Abstract][Full Text] [Related]
31. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients. Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680 [TBL] [Abstract][Full Text] [Related]
32. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12. van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061 [TBL] [Abstract][Full Text] [Related]
33. Role of endogenous IFN-gamma in macrophage programming induced by IL-12 and IL-18. Bastos KR; Barboza R; Sardinha L; Russo M; Alvarez JM; Lima MR J Interferon Cytokine Res; 2007 May; 27(5):399-410. PubMed ID: 17523872 [TBL] [Abstract][Full Text] [Related]
34. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake. Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083 [TBL] [Abstract][Full Text] [Related]
35. Differential regulation of NK cell proliferation by type I and type II IFN. Loza MJ; Perussia B Int Immunol; 2004 Jan; 16(1):23-32. PubMed ID: 14688057 [TBL] [Abstract][Full Text] [Related]
36. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12. Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085 [TBL] [Abstract][Full Text] [Related]
37. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion. Jewett A; Bonavida B Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529 [TBL] [Abstract][Full Text] [Related]
38. Expression of IFN-gamma upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors. Ortaldo JR; Young HA J Immunol; 2003 Feb; 170(4):1763-9. PubMed ID: 12574340 [TBL] [Abstract][Full Text] [Related]
39. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270 [TBL] [Abstract][Full Text] [Related]
40. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. Carson WE; Ross ME; Baiocchi RA; Marien MJ; Boiani N; Grabstein K; Caligiuri MA J Clin Invest; 1995 Dec; 96(6):2578-82. PubMed ID: 8675621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]